Akums Drugs And Pharma L
Microcap 250
₹776.35
+3.56%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.05.
- Comfortable interest cover: operating profit covers interest about 5.6 times.
- Return on capital employed is moderate at 14.9%.
- Net profit margin is 5.9%.
- Profit has compounded about 16% a year over five years.
- Sales have compounded about 10% a year over five years.
- Pays a dividend (yield about 0.13%).
- Promoters hold a majority stake (75.26%).
!Watch-points
- Return on equity is on the lower side at 8.5%.
- Recent profit growth (-7%) is slower than the five-year pace (16%).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
3.32
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Computed without the working-capital term (current-asset split not available for this stock).
Piotroski F-ScoreModerate
4 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 11,886 Cr
Current Price₹ 776.35
High / Low₹ 796.55 / 409.30
Stock P/E40.81756
Book Value₹ 211.00
Dividend Yield0%
ROCE14.90%
ROE8.45%
Face Value₹ 2.00
Debt to Equity0.05
PEG Ratio1.38
EV / EBITDA18.28
Industry PE35.70
P/B Ratio3.587337
EPS₹ 16.21
Debt₹ 157 Cr
PAT Margin5.87%
Cash PAT₹ 411 Cr
ICR5.55
Promoter Holding75.26%
FII Holding1.91%
DII Holding13.44%
Public Holding6.67%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity